Glechoma longituba (Nakai) Kupr. is a perennial shade plant with pharmaceutical importance. The aim of this study was to investigate the effects of light intensity on the growth, photosynthesis, and accumulation of secondary metabolites in G. longituba grown under six different light environments. The high light intensity decreased the leaf size, specific leaf area, and aboveground dry mass, the number of grana per chloroplast, the number of lamella per granum, the thickness of the grana, the apparent quantum efficiency, the chlorophyll (Chl) content, the concentrations of ursolic and oleanolic acid. The high light increased the stomatal density, the stoma size, the number of chloroplast per a cell, the chloroplast size, the dark respiration rate, the light saturation point, the light compensation point, and the Chl a/b ratio. With the reduction in the light intensity, the light-saturated net photosynthetic rate, the aerial dry mass per plant, and the yields of ursolic and oleanolic acid decreased after an initial increase, peaking at 16 and 33% of sunlight levels. Overall, the 16 and 33% irradiance levels were the most efficient in improving the yields and qualities of the medicinal plant. The lower light demand and growth characteristics suggest that G. longituba is an extremely shade-tolerant plant and that appropriate light intensity management might be feasible to obtain higher yields of secondary metabolites in agricultural management.

The level of CHB virus (HBV) core antibody (HBcAb) is different in four stages of chronic HBV infection and may be used for differential diagnosis of the natural history of chronic HBV infection. To address this question, we examined multiple blood biomarkers and assessed the efficacy to diagnose different stages of chronic HBV infection. The quantitative detection of HBcAb, hepatitis B surface antigen (HBsAg), HBV DNA, alanine aminotransferase (ALT), aspartate aminotransferase (AST), and platelet count (PLT) were determined in the serum of 73 cases of low-replicative phase (LR), 46 cases of immune-tolerant phase (IT), 44 cases of immune clearance phase (IC), and 57 cases of HBeAg-negative hepatitis (ENH). Differentiating performance of these serum protein levels was analyzed by receiver operating characteristic (ROC) curve analysis. Our results showed that the levels of HBcAb, ALT, and AST levels were significantly higher in IC and ENH than those in LR and IT (both P ≤ 0.001 ). The levels of HBV DNA and HBsAg were higher in IC and IT than those in LR and ENH (both P ≤ 0.001 ). Logistic regression models showed that HBcAb, HBsAg, HBV DNA, ALT, and AST were the independent variables, respectively, and when combined, they provided high diagnostic accuracy for the staging of CHB. To sum up, HBcAb quantification is a new index, which can reflect whether the liver is in the immune activation state of HBV infection, and is related to the inflammatory state of the host liver. The combined detection of HBcAb quantification and other indicators has showed promising efficiency for staging of IC and ENH and can assist the diagnosis and treatment of CHB.

Seventeen new derivatives of betulinic acid (BA) with potential anti-tumor activity have been synthesized. In order to improve the bioactivity of BA, we connected BA and nitric oxide donors together via different linkers. The results of the biological activity of these derivatives showed that four compounds exhibited obvious cytotoxicity against human hepatocellular carcinoma cells in vitro.

No abstract